Oligoastenoteratospermia: Treatment and How to Get Pregnant

By (senior embryologist), (gynecologist), (embryologist), (embryologist) and (biochemist).
Last Update: 08/21/2026

Oligoasthenoteratospermia (OAT) is the name of a sperm disorder in which three different sperm parameters are affected at the same time: sperm count, sperm motility, and sperm morphology. It is also known as oligoasthenoteratozoospermia.

For a couple in which the male partner suffers from oligoasthenoteratospermia, achieving a natural pregnancy can be complicated. Therefore, it is most likely that the couple will have turn to in vitro fertilization techniques in order to get pregnant and become parents.

Definition of the condition

The term oligoasthenozoospermia is result of combining three different sperm abnormailities:

Oligospermia
low sperm concentration in the ejaculate, less than 15 million/ml.
Asthenospermia
poor sperm motility, more than 60 percent are immotile or less than 32% have progressive motility
Teratospermia
abnormal sperm morphology, over 96 percent haveing an abnormal shape.

Although the World Health Organization (WHO) published an update to the Laboratory Manual for the Examination and Processing of Semen in 2021 (the sixth edition), the criteria from the fifth edition (from 2010) are still most commonly used.

Oligoasthenoteratozoospermia is, therefore, a cause of male infertility, as the combination of the sperm abnormalities prevents the sperm from being able to meet the egg and fertilize it.

This doesn´t mean that natural conception is impossible, especially if the results of the semen analysis are only slightly below the reference values. However, the chances of achieving pregnancy diminish dramatically with worsening sperm quality.

Causes

Determining the specific causes leading to oligoasthenoteratospermia is hard, mainly because it can be the result of a combination between different factors. Defects in the sperm production process (spermatogenesis), or disorders in the male reproductive system can diminish the sperm quality and potential fertility of the male.

It takes about 3 months to complete the process of spermatogenesis, which involves the sucessive division of the stem cells in the seminiferous tubules. Throughout the process, the cells go through different structural changes until they become sperm cells.

The following are some of the most common causes associated with oligoasthenoteratospermia in males:

  • Hormonal alterations affecting spermatogenesis
  • Consumption of certain medications, including anabolic steroids, antidepressants, and chemotherapy
  • Lifestyle: poor diet, alcohol, smoking etc.
  • Testicular birth defects
  • Testicular disorders, such as varicocele
  • Infections in the seminal ducts, like prostatitis
  • Genetic problems that affect sperm production

To try to recover male fertility and improve oligoasthenoteratozoospermia, one can try to correct any hormonal alterations with medication or even correct the testicular problems by surgery. In contrast, if the cause is an infection, antibiotics will be prescribed.

However, for the vast majority of patients with severe oligoasthenoteratozoospermia there is no alternative but to resort to Assisted Reproductive Technology (ART) to become parents.

How to achieve pregnancy

The treatment of OAT will be determined according to the factor or factors that are causing it. If it is due to an easily diagnoised disorder like varicocele, your physician may consider surgery as the best treatment option.

If the problem is a blockage due to an infection, a course of antibiotics is required. In the same fashion, hormonal medication would be used to treat hormone imbalances.

When oligoasthenoteratosoermia is due to idiopathic causes, that is to say an unkown cause, the most appropriate option would be a fertility treatment. Some patients, however, prefer to give a natural remedies a chance before moving on to ART.

Natural remedies

The first thing a man should do after obtaining an OAT diagnosis is to consider changing his lifestyle habits for better general health. Easting a balanced diet, taking moderate exercise and quitting unhealthy habits are all steps that can improve the quality of the sperm in a few months.

Some vitamin supplements and natural remedies can be helpful as well. For example, maca root is a common natural remedy among men that may help to improve sperm quality.

Oxidative stress can have a highly negative impact on sperms due to the influence of reactive oxygen species (ROS), which compromise their functionality. For this reason, adding antioxidants such as vitamin E, vitamin C, and glutathione to your diet can help reduce the impact of sperm damage caused by oxidative stress.

It is important to stress that natural remedies and dietarty supplements should be taken under the guidance of a specialist.

Assisted Reproductive Technology (ART)

If pregnancy is not achieved after one year trying to conceive (or 6 months if the woman is older than 35 - 38 years old), or in cases of severe oligoasthenoteratospermia, fertility treatment may be required in order to become parents.

In cases of severe OAT, the technique of choice is IVF with ICSI (Intracytoplasmic Sperm Injection). Once the semen sample is collected, embryologists study the sample under a microscope and select the sperm cells with the best motility and morphology. These best sperm are then injected directly into the egg cells, with only one sperm cell needed per egg.

With ICSI, embryologists can to make sure that egg fertilization has taken place and evaluate if it has resulted in viable embryos. The best quality embryo(s) will then be transferred to the uterus of the prospective mother with the aim of implantation and initiating the pregnancy.

If you need to undergo IVF to become a mother, we recommend that you generate your Fertility Report now. In 3 simple steps, it will show you a list of clinics that fit your preferences and meet our strict quality criteria. Moreover, you will receive a report via email with useful tips to visit a fertility clinic for the first time.

FAQs from users

What reproductive options are available for oligoasthenozoospermia?

The clinical picture of oligoasthenozoospermia refers to a combination of several factors. Specifically, it refers to a decrease in the quantity, motility and morphological alterations of spermatozoa.

For this reason, the best option for treatment and achieving pregnancy would be in vitro fertilisation with optimal sperm selection, i.e. IVF-ICSI.

Can oligoastenoteratozoospermia be cured?

Oligoastenothermalospermia may be cured depending on its cause. For example, varicocele can be treated with surgery or hypogonadotropic hypogonadism with hormonal drugs.

In cases where the exact cause of oligoastenatozoospermia is not known, empirical treatment with antioxidants or antiestrogens may be used. These treatments must last at least three months and their effectiveness has not been proven.

Therefore, there are only a few patients with oligoastenothermia who can benefit from a specific treatment, the rest of patients could use empirical treatments and try to lead a healthy lifestyle. In most cases, assisted reproduction is the only treatment for them.
Read more

What is the best treatment for a case of severe oligoasthenoteratozoospermia?

When a man has an abnormal semen analysis in which the parameters for sperm concentration, motility, and morphology fall outside the reference ranges, the chances of achieving a natural pregnancy or one through simple assisted reproductive technologies are very low.

In these cases—where there are few sperm, limited motility, and abnormal sperm morphology—the assisted reproductive technology with the highest chance of success is ICSI (intracytoplasmic sperm injection). This technique allows embryologists to select sperm and inject them directly into the eggs. As a result, only as many sperm are needed as there are eggs to be fertilized.

In contrast, artificial insemination is not possible in cases of oligoastenoteratozoospermia, since the sperm would need to travel and fertilize the egg on their own.

Can you do IUI with oligoasthenoteratospermia?

Artificial insemination is a simple, minimally invasive technique in which the egg and sperm must meet on their own in the woman’s fallopian tubes. For this reason, it is not the appropriate assisted reproductive technology when semen quality is compromised, as in the case of oligoasthenoteratozoospermia.

In general, for artificial insemination to have a reasonable chance of success, the motile sperm count (MSC) after semen sample preparation must be greater than 5 million.

Can oligoasthenoteraozoospermia cause miscarriages?

Oligoastenoteratozoospermia does not necessarily lead to a miscarriage. However, when semen quality is severely impaired, the sperm may have certain chromosomal abnormalities that can indeed cause a miscarriage.

What is mild oligoasthenoteratozoospermia?

When oligoasthenoteratozoospermia is described as “mild,” it means that the concentration, motility, and morphology of the sperm are only mildly, or slightly, altered. Therefore, mild oligoasthenoteratozoospermia would be the same as mild oligoasthenoteratozoospermia.

How is oligoasthenoteratozoospermia diagnosed?

Oligoasthenoteratozoospermia is a combination of abnormalities in sperm concentration, motility, and morphology.

The semen analysis is the basic test for diagnosing oligoasthenoteratozoospermia. By evaluating the microscopic parameters of sperm concentration, motility, and morphology, the specialist can determine whether the man has this semen abnormality.

Specifically, and based on the 2010 criteria established by the World Health Organization (WHO), a man is considered to have oligoastenoteratozoospermia when his semen contains fewer than 15 million sperm per milliliter of ejaculate, has a motility rate of less than 40%, and a percentage of normal sperm of less than 4%.

The male fertility test that is able to detect sperm abnormalities is the semen analysis or seminogram. Read this post to learn how to interpret the results and the different aspects evaluated: What is a basic semen analysis?.

ICSI is the assisted reproductive technique that is most appropriate for fertility patients with oligoasthenoteratospermia. If you would like to read more about this subject then please visit the following link: Intracytoplasmic sperm injection: What is ICSO and how much is it?

Community and Support

At inviTRA we work to make monthly and rigorous information accessible to everyone. If this article has helped you, consider supporting us so we can continue accompanying more people on their journey to parenthood.

📢 1. Share

💬 2. Comment

❤️ 3. Donate

References

Auger J, Jouannet P, Eustache F. Another look at human sperm morphology. Hum Reprod. 2016 Jan;31(1):10-23. (View)

Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl. 2006 Mar;8(2):143-57. (View)

Colpi GM, Francavilla S, Haidl G, Link K, Behre HM, Goulis DG, Krausz C, Giwercman A. European Academy of Andrology guideline Management of oligo-astheno-teratozoospermia. Andrology. 2018 Jul;6(4):513-524. (View)

Concepción-Zavaleta M, Paz Ibarra JL, Ramos-Yataco A, Coronado-Arroyo J, Concepción-Urteaga L, Roseboom PJ, Williams CA. Assessment of hormonal status in male infertility. An update. Diabetes Metab Syndr. 2022 Mar;16(3):102447. (View)

Esteves SC. Who cares about oligozoospermia when we have ICSI. Reprod Biomed Online. 2022 May;44(5):769-775. (View)

Hologlu D, Gunes S, Asci R, Henkel R, Guvenc T. Association among sperm chromatin condensation, sperm DNA fragmentation and 8-OHdG in seminal plasma and semen parameters in infertile men with oligoasthenoteratozoospermia. Andrologia. 2022 Feb;54(1):e14268. (View)

Ma J, Wu L, Zhou Y, Zhang H, Xiong C, Peng Z, Bao W, Meng T, Liu Y. Association between BMI and semen quality: an observational study of 3966 sperm donors. Hum Reprod. 2019 Jan 1;34(1):155-162. (View)

WHO laboratory manual for the examination and processing of human semen, 5th ed. Geneva: World Health Organization; 2010. (View)

WHO laboratory manual for the examination and processing of human semen, sixth edition. Geneva: World Health Organization; 2021. (View)

FAQs from users: 'What reproductive options are available for oligoasthenozoospermia?', 'Can oligoastenoteratozoospermia be cured?', 'What is the best treatment for a case of severe oligoasthenoteratozoospermia?', 'Can you do IUI with oligoasthenoteratospermia?', 'What is the miscarriage rate with oligoasthenoteratospermia?', 'Can oligoasthenoteraozoospermia cause miscarriages?', 'What is mild oligoasthenoteratozoospermia?' and 'How is oligoasthenoteratozoospermia diagnosed?'.

Read more

Authors and contributors

 Emilio Gómez Sánchez
Emilio Gómez Sánchez
B.Sc., Ph.D.
Senior Embryologist
Bachelor's Degree in Biology from the University of Seville. PhD in Biology from the University of Valencia. Large experience as an Embryologist Specialized in Assisted Reproduction. Currently, he is the IVF Lab Director of Tahe Fertilidad. More information about Emilio Gómez Sánchez
License: 14075-MU

 Gustavo Daniel  Carti
Gustavo Daniel Carti
M.D.
Gynecologist
Dr. Gustavo Daniel Carti has a degree in medicine and specialized in obstetrics and gynecology from the University of Buenos Aires. More information about Gustavo Daniel Carti
Licence number: 070711274

 Marta Barranquero Gómez
Marta Barranquero Gómez
B.Sc., M.Sc.
Embryologist
Graduated in Biochemistry and Biomedical Sciences by the University of Valencia (UV) and specialized in Assisted Reproduction by the University of Alcalá de Henares (UAH) in collaboration with Ginefiv and in Clinical Genetics by the University of Alcalá de Henares (UAH). More information about Marta Barranquero Gómez
License: 3316-CV

 Silvia Azaña Gutiérrez
Silvia Azaña Gutiérrez
B.Sc., M.Sc.
Embryologist
Graduate in Health Biology from the University of Alcalá and specialized in Clinical Genetics from the same university. Master in Assisted Reproduction by the University of Valencia in collaboration with IVI clinics. More information about Silvia Azaña Gutiérrez
License: 3435-CV

Adapted into english by:
 Michelle Lorraine Embleton
Michelle Lorraine Embleton
B.Sc. Ph.D.
Biochemist
PhD in Biochemistry, University of Bristol, UK, specialising in DNA : protein intereactions. BSc honours degree in Molecular Biology, Univerisity of Bristol. Translation and editing of scientific and medical literature.
More information about Michelle Lorraine Embleton

Find the latest news on assisted reproduction in our channels.